interesting medical note of the Dapsone Gel. the 7.5% has much better application advantages and better complaince than the lower strength.
"Dapsone had been reported in a few cases to effectively treat acne, but the risk of hemolytic anemia kept it from being widely used for this purpose. For many years scientists attempted to develop a topical formulation of dapsone that would be as effective against acne as oral dapsone, but without the hemolysis side effect. This was difficult to accomplish because dapsone is highly insoluble in aqueous solvents. In the early 2000s QLT USA developed Aczone, a 5% dapsone gel that was shown to be effective against acne without causing clinically significant declines in hemoglobin levels, even in subjects with G6PD deficiency.[63] In February 2016, the FDA approved a 7.5% dapsone gel. This higher strength has the advantage of a once-daily application, versus twice-daily application of the 5% formulation."
- Forums
- ASX - By Stock
- Ann: FDA Approval received for Dapsone Gel, 7.5%
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

interesting medical note of the Dapsone Gel. the 7.5% has much...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $812 | 42.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 631825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 522500 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 631825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 522500 | 4 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 13.06pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |